Saturday, May 28, 2022
name of Prensa Latina
Bandera inglesa
English Edition
name of Prensa Latina

NEWS

Itolizumab

Havana, Sep 1 (Prensa Latina) A production campaign of Itolizumab, a monoclonal antibody used as a treatment for serious Covid-19 cases was recently completed, informed today authorities of the Center for Molecular Immunology (CIM) of Cuba.